PAPER
Synthesis of Cyclic Enamides and Enamines
473
Ethyl (2Z)-3-(2-Oxopyrrolidin-1-yl)prop-2-enoate (5a) and Eth-
yl (2E)-3-(2-Oxopyrrolidin-1-yl)prop-2-enoate (6a); Reactions
of Diazo Compound 4 with Rhodium(II) Acetate Catalyst; Typ-
ical Procedure
Ethyl (2E)-3-(2-Oxopiperidin-1-yl)prop-2-enoate (6b)
Yield: 139 mg (53%); colorless liquid.
IR (CHCl ): 2949, 1667, 1621 (C=C), 1451, 1411, 1292, 1259,
3
–1
1
167, 1097, 1024 cm .
To a stirred solution of the diazo compound 4a (0.30 g, 1.4 mmol)
in anhyd benzene (15 mL) was added a 0.3 mol% of Rh (OAc) un-
1H NMR: = 1.29 (t, 3 H, J = 7.1 Hz, CH ), 1.83–2.04 (complex, 4
3
2
4
H), 2.53–2.59 (m, 2 H), 3.41–3.47 (m, 2 H), 4.19 (q, 2 H, J = 7.1
der an argon atmosphere. The reaction mixture was refluxed for
5 h by following the reaction with TLC until the disappearance of
Hz, OCH ), 5.27 (d, 1 H, J = 14.6 Hz, CH), 8.60 (d, 1 H, J = 14.6
2
2
Hz, CH).
the diazo compound 4a. Then the solvent was removed under re-
duced pressure and the residue was purified using alumina column
chromatography (EtOAc–hexane, 1:2) to afford the enamides 5a
13C NMR:
= 14.2 (CH ), 20.1 (CH ), 22.2 (CH ), 33.0 (CH ), 45.5
3
2
2
2
(
CH ), 59.0 (CH ), 99.8 (CH), 140.6 (NCH), 167.3 (quat-C, CO Et),
2
2
2
(0.125 g, 40%) and 6a (0.095 g, 31%) as colorless solids.
1
69.2 (quat-C, NCO).
FD-MS: m/z = 197 (M+).
Anal. Calcd for C10
60.84; H, 7.66; N, 7.08.
Ethyl (2Z)-3-(2-Oxopyrrolidin-1-yl)prop-2-enoate (5a)
Yield: 104 mg (40%); colorless solid; mp 35–37 °C (hexanes–
EtOAc).
H
15NO : C, 60.90; H, 7.67; N, 7.10. Found: C,
3
IR (CHCl ): 2922, 1716, 1632 (C=C), 1517, 1458, 1356, 1162,
3
–1
Ethyl (2Z)-3-(2-Oxoazepan-1-yl)prop-2-enoate (5c)
Yield: 69 mg (26%); colorless solid; mp 56–58 °C (hexanes–
EtOAc).
1
042, 805 cm .
1H NMR: = 1.28 (t, 3 H, J = 7.1 Hz, CH ), 2.01–2.17 (m, 2 H),
3
2
.48 (t, 2 H, J = 8.2 Hz, CH ), 3.97 (t, 2 H, J = 7.1 Hz, CH ), 4.14
2 2
IR (KBr): 2935, 1709, 1683, 1627 (C=C), 1384, 1358, 1169, 910,
(
q, 2 H, J = 7.1 Hz, OCH ), 5.14 (d, 1 H, J = 10.6 Hz, CH), 7.10 (d,
2
–1
7
34 cm .
1
H, J = 10.6 Hz, CH).
1H NMR: = 1.28 (t, 3 H, J = 7.1 Hz, CH
), 1.73–1.89 (complex, 6
13C NMR:
3
= 14.1 (CH ), 18.5 (CH ), 30.1 (CH ), 48.5 (CH ), 59.9
3
2
2
2
H), 2.67–2.79 (m, 2 H), 3.81–3.85 (m, 2 H), 4.15 (q, 2 H, J = 7.1
(
CH ), 99.1 (CH), 133.5 (NCH), 165.3 (quat-C, CO Et), 175.8
2
2
Hz, OCH ), 5.21 (d, 1 H, J = 10.4 Hz, CH), 7.24 (d, 1 H, J = 10.4
2
(
quat-C, NCO).
Hz, CH).
+
EIMS: m/z (%) = 183 (M , 34), 154 (25), 138 (100), 110 (98), 82
98), 70 (48), 55 (31), 41 (65).
13C NMR:
CH ) 50.9 (CH ), 60.0 (CH ), 102.4 (CH), 140.1 (NCH), 165.1
= 14.2 (CH ), 23.3 (CH ), 29.2 (CH ), 29.5 (CH ), 37.2
3 2 2 2
(
(
2
2
2
Anal. Calcd for C H NO : C, 59.00; H, 7.15; N, 7.65. Found: C,
9
13
3
(quat-C, CO Et), 176.4 (quat-C, NCO).
2
5
9.08; H, 7.12; N, 7.63.
+
EIMS: m/z (%) = 211 (M , 5), 183 (3), 166 (12), 154 (22), 138
(
100), 109 (18), 96 (13), 82 (17), 79 (24), 55 (19), 41 (25), 29 (28).
Anal. Calcd for C11 : C, 62.54; H, 8.11; N, 6.63. Found: C,
62.57; H, 8.08; N, 6.61.
Ethyl (2E)-3-(2-Oxopyrrolidin-1-yl)prop-2-enoate (6a)
Yield: 80 mg (31%); colorless solid; mp 57–58 °C (hexanes–
EtOAc).
H17NO
3
IR (KBr): 2983, 2901, 1730, 1701, 1629 (C=C), 1462, 1406, 1329,
–1
Ethyl (2E)-3-(2-Oxoazepan-1-yl)prop-2-enoate (6c)
Yield: 103 mg (39%); colorless solid; mp 53–55 °C (hexanes–
EtOAc).
1
219, 915, 732 cm .
1H NMR: = 1.29 (t, 3 H, J = 7.1 Hz, CH ), 2.11–2.26 (m, 2 H),
3
2
.57 (t, 2 H, J = 8.3 Hz, CH ), 3.57 (t, 2 H, J = 7.2 Hz, CH ), 4.20
2 2
IR (CHCl ): 2938, 1709, 1621 (C=C), 1476, 1440, 1365, 1256,
3
(
q, 2 H, J = 7.1 Hz, OCH ), 5.21 (d, 1 H, J = 14.2 Hz, CH), 8.09 (d,
2
–1
1
172, 1052, 968, 911 cm .
1
H, J = 14.2 Hz, CH).
1H NMR: = 1.29 (t, 3 H, J = 7.1 Hz, CH
), 1.73–1.79 (complex, 6
13C NMR:
3
= 14.2 (CH ), 17.3 (CH ), 30.8 (CH ), 44.8 (CH ), 60.0
3
2
2
2
H), 2.68–2.73 (m, 2 H), 3.61–3.66 (m, 2 H), 4.19 (q, 2 H, J = 7.1
(
CH ), 100.6 (CH), 137.1 (NCH), 167.0 (quat-C, CO Et), 174.1
2
2
Hz, OCH ), 5.31 (d, 1 H, J = 14.5 Hz, CH), 8.43 (d, 1 H, J = 14.5
2
(
quat-C, NCO).
Hz, CH).
+
EIMS: m/z (%) = 183 (M , 35), 154 (25), 138 (99), 110 (100), 82
98), 70 (43), 41 (59).
13C NMR:
CH ) 45.2 (CH ), 59.7 (CH ), 98.5 (CH), 140.5 (NCH), 167.5
= 14.1 (CH ), 23.2 (CH ), 26.9 (CH ), 28.8 (CH ), 36.7
3 2 2 2
(
(
2
2
2
Anal. Calcd for C H NO : C, 59.00; H, 7.15; N, 7.65. Found: C,
9
13
3
(quat-C, CO Et), 174.6 (quat-C, NCO).
2
5
9.06; H, 7.13; N, 7.67.
FD-MS: m/z = 211 (M+).
Ethyl (2Z)-3-(2-Oxopiperidin-1-yl)prop-2-enoate (5b)
Anal. Calcd for C11
H17NO : C, 62.54; H, 8.11; N, 6.63. Found: C,
3
Yield: 60 mg (23%); colorless liquid.
62.48; H, 8.14; N, 6.61.
IR (CHCl ): 2956, 1709, 1623(C=C), 1475, 1409, 1262, 1161,
3
–1
Ethyl (2Z)-3-(Pyrrolidin-1-yl)prop-2-enoate (5d)
Yield: 116 mg (45%); colorless liquid.
1
095, 830, 738 cm .
1H NMR: = 1.30 (t, 3 H, J = 7.1 Hz, CH ), 1.79–1.92 (complex, 4
3
IR (CHCl ): 2921, 1718, 1633 (C=C), 1519, 1475, 1365, 1162,
3
H), 2.53–2.60 (m, 2 H), 3.72–3.78 (m, 2 H), 4.17 (q, 2 H, J = 7.1
–
1
1
045, 850 cm .
Hz, OCH ), 5.27 (d, 1 H, J = 10.4 Hz, CH), 7.37 (d, 1 H, J = 10.6
2
1H NMR (200 MHz, CDCl
): = 1.25 (t, 3 H, J = 7.1 Hz, CH ),
3
Hz, CH).
3
13C NMR:
1.68–1.76 (complex, 4 H), 3.16–3.21 (complex, 4 H), 4.15 (q, 2 H,
= 14.5 (CH ), 21.3 (CH ), 21.9 (CH ), 35.2 (CH ), 45.7
3
2
2
2
J = 7.1 Hz, OCH ), 4.62 (d, 1 H, J = 13.1 Hz, CH), 7.36 (d, 1 H,
2
(
CH ), 59.2 (CH ), 100.4 (CH), 135.7 (NCH), 165.6 (quat-C,
2 2
J = 13.1 Hz, CH).
CO Et), 171.4 (quat-C, NCO).
2
13C NMR (50.3 MHz, CDCl
CH ), 60.0 (OCH ), 84.3 (CH), 152.7 (NCH), 170.5 (quat-C,
): = 14.7 (CH ), 25.5 (CH ), 50.1
3 2
FD-MS: m/z = 197 (M+).
3
(
2
2
Anal. Calcd for C H NO : C, 60.90; H, 7.67; N, 7.10. Found: C,
10
15
3
CO Et).
2
6
0.97; H, 7.65; N, 7.13.
FD-MS: m/z = 169 (M+).
Synthesis 2002, No. 4, 471–474 ISSN 0039-7881 © Thieme Stuttgart · New York